“Pharmaceutical executives who recently made a major donation to an anti-marijuana legalization campaign claimed they were doing so out of concern for the safety of children — but their investor filings reveal that pot poses a direct threat to their plans to cash in on a synthetic cannabis product they have developed.”
Related Posts
Cannabis link to relieving intestinal inflammation explained
- WOCredentials
- August 18, 2018
- 0
“new research from the University of Massachusetts Medical School and the University of Bath showing that endocannabinoids help control and prevent intestinal inflammation in mice”
Medical Marijuana Reduces Prescription Drug Use, Says New Research
- WOCredentials
- July 20, 2016
- 0
“Medical cannabis laws are associated with significant reductions in opioid prescribing in the Medicare Part D population. This finding was particularly strong in states that permit dispensaries, and for reductions […]
Cannabinoids and the immune system: an overview (2010)
- WOCredentials
- June 16, 2016
- 0
“Cannabinoids can modulate immune reactions in the periphery but also in the brain, influence T cell subset balance and cytokine expression and play a role in the balance between neuroinflammation […]